Articles
Latest reporting, analysis, interviews and insight from The Pharma Navigator editorial team.
-
-
Regulatory & ComplianceBioNTech Faces NIH Default Notice Over COVID-19 Vaccine Royalties
4 min read • 2 years ago -
Funding & InvestmentsSanofi and Owkin Intensify AI Alliance to Revolutionize Immunology Drug Development
4 min read • 2 years ago -
Manufacturing ServicesNovo Nordisk Acquires Cardior Pharmaceuticals to Boost Cardiovascular Pipeline
4 min read • 2 years ago -
-
Funding & InvestmentsLilly Reinforces Chinese Market Commitment Amidst US-China Biotech Tensions
4 min read • 2 years ago -
Drug Delivery & PackagingJ&J Sues Ex-Employee Over Alleged Theft of Trade Secrets for Pfizer
4 min read • 2 years ago -
-
-
-
Manufacturing ServicesIs 2024 the Year for Resurgence in the Biotech Sector?
4 min read • 3 years ago -
Regulatory & ComplianceSouth Africans Take on Pharmaceutical Company Vertex
4 min read • 3 years ago
Join 50,000+ Pharma Professionals
Receive exclusive market analysis, biotech trends, regulatory intelligence, and executive briefings.
Advertisement here
As billionaires pour capital into age-reversal biotech, the ethical implications for public healthcare systems are.







